BACKGROUND: Although physical activity (PA) can alleviate fatigue and improve quality of life (QoL) in patients with breast cancer (BC), not all domains of PA may have equal impact. The objective of the current study was to examine the longitudinal impact of PA components on the evolution of fatigue and QoL during and after adjuvant treatment for BC. METHODS: The women included in the study were participants in the 2-year longitudinal FATSEIN ("Fatigue dans le cancer du Sein") study. Fatigue and QoL were measured using the Multidimensional Fatigue Inventory and the European Organization for Research and Treatment of Cancer 30-item QoL questionnaire, respectively. Group-based trajectory analysis was used to determine patterns of PA evolution (frequency, duration, and intensity). Cross-sectional and longitudinal associations between PA patterns and fatigue and QoL were analyzed by using multivariable linear regression and a mixed model. RESULTS: Among the 424 women who were included (mean 6 standard deviation age, 57.1 6 10.4 years), 2 trajectories were identified for each of the 3 PA components: low and insufficient frequency (51.2%) or regular and moderate frequency (48.8%), low and insufficient duration (47.6%) or regular and moderate duration (52.4%), and low intensity (47.2%) or low to moderate intensity (52.8%). Overall, during treatment, fatigue was increased and QoL was decreased, and the reverse was observed after treatment. During treatment, increased fatigue and decreased QoL were limited by regular PA frequency (b 5 28.71 for total fatigue; b 5 14.59 for emotional function), but the results were less significant after treatment. CONCLUSIONS: PA, especially its frequency, is an important determinant of fatigue and QoL during adjuvant treatment for BC. The promotion of regular PA among women who are receiving treatment for BC may be an effective way to reduce fatigue and improve QoL. Cancer 2018;124:797-806.
INTRODUCTION
Paying attention to fatigue during breast cancer (BC) is essential, because it is 1 of the most common and problematic side effects reported by patients. 1 Fatigue is a complex phenomenon that differs from usual tiredness, in that it is not relieved by rest or sleep. 2 Therefore, this fatigue has a considerable impact on patients' engagement in work and personal and social activity. 1 Fatigue is associated with both the disease and the treatment. 1, 3 Indeed, from 60% to 90% of patients complain of fatigue during treatment, and 30% do so after treatment. 1 Quality of life (QoL) is an important consideration in oncology, particularly for patients with BC, and can also be affected by treatments. 4, 5 Maintenance of and improvements in QoL for patients with cancer during and after treatment are major concerns in oncology, because treatments are often intensive and traumatic. 6 For instance, the type of surgery or adjuvant therapy can induce several side effects and symptoms, such as anxiety or sleep disturbance, that can negatively affect personality and QoL. 6 Approaches for managing fatigue and QoL in patients with cancer include pharmacotherapy, cognitive-behavioral therapy, alternative medicine, support groups, and physical activity (PA). Pharmacotherapy uses drugs and cognitivebehavioral therapy and aims to deliver education about fatigue (learning self-care and how to balance activities and rest). 7 Alternative medicine includes, for example, spiritual healing, magnet therapy, and herbal preparations. 8 During support groups, patients can exchange information about their situations and feelings. 8 PA is defined as "any bodily movement produced by skeletal muscles that results in energy expenditure." 9 Many studies have demonstrated the benefits of PA for reducing mortality and morbidity in several pathologies, including BC. 10, 11 The importance of PA practice for fatigue reduction and QoL improvement has been demonstrated in patients with BC. [12] [13] [14] A meta-analysis provided evidence that PA is beneficial for managing fatigue in women with BC during and after treatment. 12 Another metaanalysis indicated that PA has beneficial effects on the general sensation of being tired, reduced activity, and reduced motivation in women with BC, 13 and a longitudinal study also demonstrated the beneficial effect of PA on QoL in these patients. 14 PA is a multidimensional and complex behavior that is subject to change over time. Four components often described for PA are frequency, intensity, time, and type. 15 Even if PA has a positive impact on fatigue and QoL, not all PA components may have equal impact. Analyzing the impact of PA on fatigue and QoL requires accounting for the complexity and evolution of PA over time. However, these conditions are often not considered. 16, 17 In a cross-sectional study, PA improved QoL and reduced fatigue in women with BC, but the evolution of PA was not studied. 17 Furthermore, a prospective study demonstrated a positive relation between PA and fatigue during BC, but the investigators did not analyze each PA component. 16 Moreover, the levels and evolution of fatigue and QoL differ during and after adjuvant treatment of BC, so the impact of PA components can differ, depending on these periods. 6, 18 Therefore, the objective of the current study was to examine the longitudinal impact of PA components on the evolution of fatigue and QoL during and after adjuvant treatment for BC.
MATERIALS AND METHODS

The FATSEIN Study
For this study, we explored a prespecified primary hypothesis of the FATSEIN ("Fatigue dans le cancer du Sein") cohort. The FATSEIN cohort study was carried out in 3 clinical centers in northeastern France between August 2008 and January 2011. The study examined cancer-related fatigue in women who received adjuvant therapy for early stage BC. 19 The study sample consisted of 466 women with breast cancer who were undergoing treatment. Inclusion criteria were women aged 18 years with newly diagnosed stage I to IIIA breast adenocarcinoma who had undergone previous surgery, provided informed consent, spoke French, and were able to complete self-report questionnaires. Patients were examined on the day before surgery (month 0 5 baseline) and underwent follow-up at months 1, 2, 4, 6, 7, 8, 12, 18 , and 24 after surgery. The treatment period was from baseline to 8 months after surgery, and the post-treatment period was from 8 to 24 months after surgery. The study protocol was previously published. 19 One of the specified objectives was to determine whether PA might be related to a reduced risk of developing fatigue after surgery. The MFI-20 is a self-reported instrument that was developed to assess fatigue in patients with cancer. It consists of 20 items in 4 dimensions (general fatigue, mental fatigue, reduced motivation, and reduced activity), which are scored on a 5-point Likert scale. 20 General fatigue (items 1-3, 5, 8, 12, 14, 16, and 20) corresponds to the general sensation of being tired; and mental fatigue (items 7, 9, 11, 13, 18, and 19) refers to cognitive aspects, such as having difficulty concentrating. 20 Reduced motivation (items 4 and 15) is difficulty imagining the ability to enjoy a pleasant activity. 20 Reduced activities (items 6, 10, and 17) correspond to the influence of physical and psychological factors on the level of activity. 20 This questionnaire has good psychometric properties and internal consistency for each subscale, with Cronbach a values ranging from .73 (reduced motivation) to .92 (general fatigue). 20 Each dimension score is calculated by summing the item response (crude score) and normalizing the crude score from 0 (no fatigue) to 100 (high fatigue). The fatigue total score is obtained by summing crude scores for each dimension and normalizing them on the scale from 0 to 100.
Quality of life
QoL was assessed with the European Organization for Research and Treatment of Cancer 30-item QoL questionnaire (EORTC QLQC-30), 21 a widely used, cancerspecific, self-administered questionnaire with strong validity. The questionnaire is composed of 30 items in 5 functional dimensions (physical, mental, cognitive, emotional, and social), 9 symptomatic dimensions (fatigue, pain, nausea and vomiting, dyspnea, sleep disturbance, loss of appetite, constipation, diarrhea, and financial impact), and 1 dimension of global health and QoL. 21 In the current study, we were interested only in the 5 functional dimensions and the global health and QoL dimension, because these are affected more often by PA. Physical functioning (items 1-5) focuses on limitations in activities like walking and carry items. Role functioning (items 6 and 7) corresponds to discomfort doing recreational daily activities. Cognitive functioning (items 20 and 25) assess difficulty concentrating. Emotional functioning (items 21 to 24) refers to psychic health, such as anxiety, depression, or irritability. Social functioning (items 26 and 27) corresponds to discomfort caused by PA in social activities. Items of the 5 functional dimensions are answered on a 4-point Likert scale from 1 (not at all) to 4 (a lot), and items of global health and QoL are answered on a 7-point Likert scale from 1 (very bad) to 7 (excellent). 21 Scores for items are summarized for each dimension and then normalized on a scale from 0 to 100 (high QoL).
Physical activity
Patients were asked to declare their PA practice during the previous month, including the type, frequency (number of sessions per month), and duration of each session (minutes). These questions were formulated similar to questions on the International Physical Activity Questionnaire. 22 The PA components measured were frequency, duration, and intensity, which refer to the number of PA sessions per week, the mean duration per PA session (in minutes per session), and the energy expenditure related to PA (metabolic equivalent task [MET]). 23 
Covariates
Weight status was calculated as the body mass index using the reported weight and height and was classified as either normal (18-25 kg/m 2 or overweight or obese (>25 kg/m 2 . Data were gathered on age (year), marital status (single, married/live-in relationship, widowed, or divorced), education level (less than secondary school, secondary school, postsecondary school but not university, or university), daily help (yes or no), residence (rural, suburban, or urban), children (none, 2, or > 3), distance between home and hospital (<20, 20-49, 50-99, or > 100 km), employment status (working or not working). Other data gathered were surgical technique (lumpectomy or mastectomy), axillary procedure (no axillary dissection, sentinel lymph node biopsy, axillary dissection or sentinel lymph node biopsy, and axillary dissection), disease stage (I, II, or III), and adjuvant treatment (with or without chemotherapy).
Statistical Analysis
The included participants were compared with excluded participants in terms of baseline fatigue, QoL, and sociodemographic and clinical characteristics using the Student t test for continuous variables and the chi-square test for categorical variables. Two-year trajectories of PA components (frequency, duration, and intensity) were identified by latent class growth analysis using the traj procedure in the SAS statistical software package (version 9.4; SAS Institute Inc, Cary, NC). 24, 25 These models allowed for identifying latent (ie, unobserved) homogeneous subpopulations within a larger heterogeneous population. 25 The optimal number of trajectories and shapes that best fit the data were based on maximization (closer to 0) of the Bayesian information criterion, the proportion of patients in each trajectory group (>5%), the statistical significance of the equation modeled (intercept only, linear, or quadratic), and the clinical meaning of identified trajectories. The Cramer V statistic was used to assess agreement between the PA trajectories identified. We analyzed the association of identified PA trajectories with baseline fatigue and QoL scores using the Student t test. Finally, we analyzed the impact of identified PA trajectories on fatigue and QoL changes during and after adjuvant treatment. Changes in fatigue and QoL were calculated for each identified trajectory using a paired Student t test. Then, we compared changes between different trajectories by hierarchical mixed models that were adjusted for covariates (sociodemographic and clinical factors). Hierarchical mixed models were performed separately for the periods during and after treatment. To limit the number of tests performed with each fatigue and QoL dimension, only 1 model that included the frequency, duration, and intensity trajectories identified was used. Tests were 2-sided, and P < .05 was considered statistically significant. Statistical analyses involved the use of SAS statistical software (version 9.4; SAS Institute, Inc).
RESULTS
From the initial sample (n 5 466), 42 patients (9%) without PA data at inclusion were excluded. Thus, 424 patients (mean 6 standard deviation age, 57.1 6 10.4 years) were included in our study. The included and excluded patients did not differ in terms of sociodemographic or clinical characteristics at the time of inclusion, except for weight status (Table 1) ; among included patients, there was an equal distribution of women with normal weight and overweight or obese status, whereas 73% of the excluded patients were normal weight (P 5 .004). One-half of the patients (n 5 208) were Two groups of 2-year trajectories were identified for each PA component (Fig. 1) . Trajectories of frequency were low and insufficient frequency (LIFreq) (n 5 217; 51.2% of women) and regular and moderate frequency (RMFreq) (n 5 207; 48.8% of women). Patients in the LIFreq group practiced less than 1 PA session per week (mean, 0.36 PA sessions per week), and those in the RMFreq group practiced PA a mean of 3 sessions per week. Trajectories of duration were low and insufficient duration (LIDur) (n 5 202; 47.6% of women) and regular and moderate duration (RMDur) (n 5 222; 52.4% of women). The mean PA duration was 8.4 and 56.2 minutes per session for the LIDur and RMDur groups, respectively. Trajectories of intensity were low intensity (Lint) (n 5 201; 47.2% of women) and low to moderate intensity (LMint) (n 5 223; 52.8% of women). The mean PA intensity was <3.3 MET and from 3.3 to 4.0 MET for the Lint and LMint groups, respectively. Similar trajectories were observed for each component with good agreement (Cramer V statistic > 0.85) ( Table 2) .
Associations of PA Trajectories With Baseline Fatigue and QoL
Baseline fatigue was significantly greater for women who had trajectories with low versus moderate PA, regardless of the component (Table 3) . For PA frequency, the mean fatigue total score was higher with LIFreq than with RMFreq (43.5 vs 37.8; P 5 .0002). Similar results were observed for duration and intensity trajectories. Moreover, compared with moderate PA trajectories, baseline QoL was lower for physical, role, and general health dimensions among patients who had low PA trajectories. For example, the mean physical function score was 85.9 and 93.1 for the LIDur and RMDur groups, respectively (P < .001). No significant difference was observed for the cognitive, social, or emotional dimensions of QoL.
Impact of PA Trajectories on Changes in Fatigue and QoL
Fatigue total scores increased during treatment (range, 6.4-10.9) and decreased after treatment (range, 24.1 to 25.1) for all PA trajectories (Table 4) . However, the impact of PA on changes in fatigue was not similar for the PA components. During treatment, the increase in total fatigue score was less in the RMFreq group than in the LIFreq group (b 5 28.71; 95% confidence interval [CI] 217.34, 20.18; P 5 .04), but PA duration and intensity did not affect change in fatigue. Similar results were observed for the physical and mental dimensions of fatigue. Compared with the period during treatment, the period after treatment exhibited no differential change in fatigue among the identified PA trajectories. PA components were not determinants of changes in fatigue after treatment. Except for emotional function, QoL decreased during treatment (range, 24 to 217) and increased after treatment (range, 2.6-9.6) for all PA trajectories (Table 5) . 
DISCUSSION
This study highlights the important and positive effect of PA, especially its frequency, on fatigue and QoL during adjuvant treatment for BC. Regular PA, whatever the duration or intensity, is an important factor in managing fatigue and QoL during treatment. PA had more impact on fatigue and QoL during treatment than after treatment. No significant association was observed after treatment between PA components and fatigue, but PA components were associated with a few dimensions of QoL.
The 2-year trajectory analysis identified coherent and consistent trajectories of PA components and highlighted 2 important results. First, women with low PA before treatment retained low PA during and after adjuvant treatment, whereas those with moderate PA retained a stable PA or had a slight increase in PA. Nonetheless, other studies demonstrated a modification in PA practice during treatment, whereas PA practice remained stable in our study. 26 In the current study, we could not measure PA before BC diagnosis. Second, components of PA were highly correlated, because women with moderate or high PA frequency were also more likely to have moderate or high PA duration and moderate PA intensity; therefore, increasing 1 of these components can increase the other.
In this study, we produced evidence of the impact of PA on fatigue and QoL at baseline and during treatment. The low PA groups started the study with higher fatigue and lower QoL than the moderate PA groups, and the differences in fatigue and QoL between the PA groups increased during treatment. Therefore, PA allows for limiting the increased fatigue and decreased QoL with treatment, and the impact of PA practice is important both Figure 1 . Identified trajectories of (a) physical activity frequency, (b) duration, and (c) intensity from inclusion to 24 months are illustrated. Data are means with 95% confidence intervals (CI). LIDur indicates low and insufficient duration; LIFreq, low and insufficient frequency; Lint, low intensity; LMint, low to moderate intensity; MET, metabolic equivalent task; RMDur, regular and moderate duration; RMFreq, regular and moderate frequency.
before and during treatment. Implementing a PA schedule during BC may be an efficient solution for managing fatigue and QoL for patients with BC.
Among the PA components, only PA frequency limited the increase in fatigue and the decrease in QoL during treatment, with no more effect after treatment. This finding can be explained by the impact of adjuvant therapy during and after treatment. Fatigue and QoL are more negatively impacted by adjuvant therapy during treatment. 2 Thus, the effect of PA, especially its frequency, is greater during treatment than after treatment. Moreover, patients with moderate PA frequency had stable PA during the study even after treatment. Because fatigue and QoL are impacted more during treatment than after treatment, women should increase their PA practice during treatment. Consequently, any PA intervention to alleviate fatigue and improve QoL during BC should be more effective during treatment.
Our study has several limitations. PA was assessed with a questionnaire that was designed for the study. However, the questions used were similar to those on the International Physical Activity Questionnaire, which was validated in a French population. 22 Objective measures could have been used to assess PA. However, our large sample size and the number of follow-up visits would have made it complicated. Moreover, subjective measurement of PA in public health studies is fairly common. It is possible that PA before inclusion predicted baseline fatigue and QoL, and the relation between PA and fatigue/QoL can be bidirectional. Nevertheless, we had no available data on PA before inclusion in our cohort, and the possible bidirectional relation means that participating in 1 (eg, PA) can result in an effect on the other (fatigue). Thus, PA can be an important lever in the management of fatigue and QoL during treatment. It would be interesting to simultaneously investigate the impact of both PA and sedentary behavior on fatigue and QoL. Unfortunately, sedentary behavior was not assessed in the current study. In addition, among the 4 components of PA (frequency, intensity, time, and type), the impact of PA type could not be explored. Despite these limitations, our study has some strengths. First, compared with other studies, in this study, we analyzed the impact of different components of PA on fatigue and QoL during and after In conclusion, this study provides evidence that PAespecially its frequency-is an important determinant of fatigue and QoL during treatment for BC. These results confirm the interest in analyzing PA components and their evolution for managing fatigue and QoL in patients with BC. Promoting PA at least 3 times per week during treatment among women with BC may be an effective strategy for reducing fatigue and improving QoL.
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